Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

Stereotactic body radiation therapy in multiple organ sites.

Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L.

J Clin Oncol. 2007 Mar 10;25(8):947-52. Review.

PMID:
17350943
2.

The North American experience with stereotactic body radiation therapy in non-small cell lung cancer.

Timmerman RD, Park C, Kavanagh BD.

J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S101-12.

3.

Stereotactic body radiation therapy: a comprehensive review.

Chang BK, Timmerman RD.

Am J Clin Oncol. 2007 Dec;30(6):637-44. Review.

PMID:
18091059
4.

Lung cancer: a model for implementing stereotactic body radiation therapy into practice.

Timmerman R, Abdulrahman R, Kavanagh BD, Meyer JL.

Front Radiat Ther Oncol. 2007;40:368-85. Review.

PMID:
17641520
5.

Versatility of the Novalis system to deliver image-guided stereotactic body radiation therapy (SBRT) for various anatomical sites.

Teh BS, Paulino AC, Lu HH, Chiu JK, Richardson S, Chiang S, Amato R, Butler EB, Bloch C.

Technol Cancer Res Treat. 2007 Aug;6(4):347-54.

PMID:
17668943
6.

Stereotactic body radiation therapy: a novel treatment modality.

Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD.

Nat Rev Clin Oncol. 2010 Jan;7(1):44-54. doi: 10.1038/nrclinonc.2009.188. Review. Erratum in: Nat Rev Clin Oncol. 2010 Aug;7(8):422. Dosage error in article text.

PMID:
19997074
7.

Extracranial radiosurgery (stereotactic body radiation therapy) for oligometastases.

Kavanagh BD, McGarry RC, Timmerman RD.

Semin Radiat Oncol. 2006 Apr;16(2):77-84. Review.

PMID:
16564443
8.

Tomotherapeutic stereotactic body radiation therapy: Techniques and comparison between modalities.

Fuss M, Shi C, Papanikolaou N.

Acta Oncol. 2006;45(7):953-60.

PMID:
16982563
9.

Stereotactic body radiation therapy: transcending the conventional to improve outcomes.

Dilling TJ, Hoffe SE.

Cancer Control. 2008 Apr;15(2):104-11. Review.

10.

Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced, and 7 metastatic lung cancers.

Salazar OM, Sandhu TS, Lattin PB, Chang JH, Lee CK, Groshko GA, Lattin CJ.

Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):707-15. doi: 10.1016/j.ijrobp.2008.01.054.

PMID:
18455322
11.

Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.

Fritz P, Kraus HJ, Blaschke T, Mühlnickel W, Strauch K, Engel-Riedel W, Chemaissani A, Stoelben E.

Lung Cancer. 2008 May;60(2):193-9.

PMID:
18045732
12.

Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus.

Song SY, Choi W, Shin SS, Lee SW, Ahn SD, Kim JH, Je HU, Park CI, Lee JS, Choi EK.

Lung Cancer. 2009 Oct;66(1):89-93. doi: 10.1016/j.lungcan.2008.12.016.

PMID:
19168260
13.

Imaging changes after stereotactic body radiation therapy for lung and liver tumors.

Lo SS, Teh BS, Wang JZ, Huang Z, Zook J, Price T, Mayr NA, Grecula JC, Timmerman RD, Cardenes HR.

Expert Rev Anticancer Ther. 2011 Apr;11(4):613-20. doi: 10.1586/era.10.164. Review.

PMID:
21504327
14.

Accreditation and quality assurance for Radiation Therapy Oncology Group: Multicenter clinical trials using Stereotactic Body Radiation Therapy in lung cancer.

Timmerman R, Galvin J, Michalski J, Straube W, Ibbott G, Martin E, Abdulrahman R, Swann S, Fowler J, Choy H.

Acta Oncol. 2006;45(7):779-86. Review.

PMID:
16982540
15.

Stereotactic body radiation therapy for liver metastases.

Dawood O, Mahadevan A, Goodman KA.

Eur J Cancer. 2009 Nov;45(17):2947-59. doi: 10.1016/j.ejca.2009.08.011. Review.

PMID:
19773153
16.

Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.

Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE.

J Clin Oncol. 2009 Apr 1;27(10):1572-8. doi: 10.1200/JCO.2008.19.6329.

PMID:
19255321
17.

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases.

Rusthoven KE, Kavanagh BD, Burri SH, Chen C, Cardenes H, Chidel MA, Pugh TJ, Kane M, Gaspar LE, Schefter TE.

J Clin Oncol. 2009 Apr 1;27(10):1579-84. doi: 10.1200/JCO.2008.19.6386.

PMID:
19255320
18.

Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.

Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, Huang Z, Grecula JC, Lo SS.

Discov Med. 2010 May;9(48):411-7. Review.

19.

Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study.

Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):677-82. doi: 10.1016/j.ijrobp.2008.11.042.

PMID:
19251380
20.

Stereotactic body radiation therapy for oligometastases.

Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, Papiez L, McGarry RC, Wang JZ, Li K, Mayr NA, Timmerman RD.

Expert Rev Anticancer Ther. 2009 May;9(5):621-35. doi: 10.1586/era.09.15. Review. Erratum in: Expert Rev Anticancer Ther. 2009 Sep;9(9):1348.

PMID:
19445579
Items per page

Supplemental Content

Support Center